** Test maker OraSure Technologies Inc's shares OSUR.O
rise 6% to $3.88 before the bell
** Co says it received an $8.6 million U.S. government
contract to develop second generation Ebola test with improved
sensitivity, increased shelf life compared to existing one
urn:newsml:reuters.com:*:nGNX8cCdjb
** Earlier this month, Uganda confirmed seven cases of Ebola
urn:newsml:reuters.com:*:nL1N30T0TV
** Up to Tuesday's close, stock lost ~58% YTD
(Reporting by Khushi Mandowara)
((Khushi.Mandowara@thomsonreuters.com;))